Cargando…

Proton Beam Therapy in the Oligometastatic/Oligorecurrent Setting: Is There a Role? A Literature Review

SIMPLE SUMMARY: Stereotactic ablative radiotherapy (SABR) and stereotactic radiosurgery (SRS) with conventional photon radiotherapy (XRT) are well-established treatment options for oligorecurrent/oligometastatic disease. Here, we review the available evidence surrounding the current use of proton be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaito, Simona, Marvaso, Giulia, Ortiz, Ramon, Crellin, Adrian, Aznar, Marianne C., Indelicato, Daniel J., Pan, Shermaine, Whitfield, Gillian, Alongi, Filippo, Jereczek-Fossa, Barbara Alicja, Burnet, Neil, Li, Michelle P., Rothwell, Bethany, Smith, Ed, Colaco, Rovel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177340/ https://www.ncbi.nlm.nih.gov/pubmed/37173955 http://dx.doi.org/10.3390/cancers15092489

Ejemplares similares

Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer
por: Marvaso, Giulia, et al.
Publicado: (2022)

Defining the role of high-dose radiation in oligometastatic & oligorecurrent cervical cancer
por: Mangaj, Akshay, et al.
Publicado: (2021)

Radiotherapy in Oligometastatic, Oligorecurrent and Oligoprogressive Prostate Cancer: A Mini-Review
por: Yaney, Alexander, et al.
Publicado: (2022)

Late Dental Toxicities After Proton Chemoradiation for Rhabdomyosarcoma: A Pediatric Case Report
por: Foster-Thomas, Emma, et al.
Publicado: (2022)

Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: a single centre analysis of toxicity and clinical outcome
por: Riva, Giulia, et al.
Publicado: (2017)

A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group
por: Marvaso, Giulia, et al.
Publicado: (2023)

Radioablation +/− hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)
por: Marvaso, Giulia, et al.
Publicado: (2019)

Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies
por: Marvaso, Giulia, et al.
Publicado: (2021)

Reply to ‘Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’’
por: Triggiani, Luca, et al.
Publicado: (2018)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
por: Mazzola, Rosario, et al.
Publicado: (2019)

Radiotherapy in nodal oligorecurrent prostate cancer
por: Pinkawa, Michael, et al.
Publicado: (2021)

Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone
por: Mistretta, Francesco A., et al.
Publicado: (2022)

Upfront Advanced Radiotherapy and New Drugs for NSCLC Patients with Synchronous Brain Metastases: Is the Juice Worth the Squeeze? A Real-World Analysis from Lombardy, Italy
por: Corrao, Giulia, et al.
Publicado: (2023)

COVID-19 manifestation in the oral cavity – a narrative literature review
por: Kusiak, Aida, et al.
Publicado: (2021)

Node Oligorecurrence in Prostate Cancer: A Challenge
por: Zapatero, Almudena, et al.
Publicado: (2023)

Evolution of Multidisciplinary Brain Metastasis Management: Case Study and Literature Review
por: Colaco, Rovel, et al.
Publicado: (2015)

Radiation Necrosis – A Growing Problem in a Case of Brain Metastases Following Whole Brain Radiotherapy and Stereotactic Radiosurgery
por: Song, Yee Pei, et al.
Publicado: (2018)

Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study
por: Triggiani, Luca, et al.
Publicado: (2017)

Combination of dabrafenib and radiotherapy: could skin toxicity be affected by different irradiation techniques?
por: Alterio, Daniela, et al.
Publicado: (2016)

Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy
por: Zaffaroni, Mattia, et al.
Publicado: (2022)

Any Role of PIK3CA and PTEN Biomarkers in the Prognosis in Oral Squamous Cell Carcinoma?
por: Starzyńska, Anna, et al.
Publicado: (2020)

Exploring miRNA Signature and Other Potential Biomarkers for Oligometastatic Prostate Cancer Characterization: The Biological Challenge behind Clinical Practice. A Narrative Review
por: Corrao, Giulia, et al.
Publicado: (2021)

Assessment of awareness of human papillomavirus infection impact on oral cavity among patients
por: Oleszkiewicz-Śpiołek, Justyna, et al.
Publicado: (2020)

Lung Radiofrequency Ablation: Potential as a Therapy to Oligometastasis and Oligorecurrence
por: Hiraki, Takao, et al.
Publicado: (2012)

Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases
por: Berkovic, Patrick, et al.
Publicado: (2020)

Repeated Multimodality Ablative Therapies for Oligorecurrent Pulmonary Metastatic Disease
por: Macagno, Alban, et al.
Publicado: (2022)

Whole-body magnetic resonance imaging: technique, guidelines and key applications
por: Summers, Paul, et al.
Publicado: (2021)

Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance
por: Triggiani, Luca, et al.
Publicado: (2021)

Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes
por: Wang, Huan-Huan, et al.
Publicado: (2016)

Metastasis-directed therapy: a new standard for oligorecurrent prostate cancer?
por: Zilli, Thomas, et al.
Publicado: (2018)

Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer
por: Stefan A. Koerber, et al.
Publicado: (2020)

Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease
por: Willmann, Jonas, et al.
Publicado: (2022)

High PD-L1 Expression on Tumor Cells Indicates Worse Overall Survival in Advanced Oral Squamous Cell Carcinomas of the Tongue and the Floor of the Mouth but Not in Other Oral Compartments
por: Adamski, Łukasz Jan, et al.
Publicado: (2021)

Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature review
por: Starzyńska, Anna, et al.
Publicado: (2020)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
por: Navarria, Pierina, et al.
Publicado: (2014)

Altered fractionation in radiation therapy for breast cancer in the elderly: are we moving forward?
por: Pinzi, Valentina, et al.
Publicado: (2020)

Oligometastasis and local ablation in the era of systemic targeted and immunotherapy
por: Mazzola, Rosario, et al.
Publicado: (2020)

Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic
por: Magrini, Stefano Maria, et al.
Publicado: (2020)

Pulmonary large cell neuroendocrine carcinoma with adrenal oligorecurrence successfully treated by adrenalectomy
por: Sato, Hiroki, et al.
Publicado: (2020)

Recent advances in radiation oncology
por: Garibaldi, Cristina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sovkac9hcn2t03eupg2gjchtp7